Significance of antiglobulin test in clinical diagnosis
Keywords:
-Abstract
-
Downloads
References
Hannon JL. Management of blood donors and blood donations from individuals found to have a positive direct antiglobulin test. Transfus Med Rev. 2012;26:142-52.
Lin JS, Hao TC, Lyou JY, Chen YJ, Liu HM, Tzeng CH, et al. Clinical application of a flow cytometric direct antiglobulin test. Transfusion. 2009 Jul;49:1335-46.
Kaplan HS, Garratty G. Predictive value of direct antiglobulin test results. Diagn Med. 1985;8:29–32.
Garratty G. The significance of IgG on the red cell surface. Transfus Med Rev. 1987;1:47-57.
Freedman J. The significance of complement on the red cell surface. Transfus Med Rev. 1987;1:58-70.
Gorst DW, RawLinson VI, Merry AH, Stratton F. Positive direct antiglobulin test in normal individuals. Vox Sang. 1980;38:99-105.
Rottenbery Y, Yahalom V, Shimar E, Barchana M, Adler B, Paltiel O. Blood donors with positive direct antiglobulin test are at risk for cancer. Transfusion. 2009;49:838-42.
Bohnen RF, Ultmann JE, Gorman JG, Farhangi M, Scudder J. The direct Coombs’ test: its clinical significance: study in a large university hospital. Ann Intern Med. 1968;68:19-32.
Garratty G. Drug-induced immune hemolytic anemia. Hematology Am Soc Hematol Educ Program. 2009;2009:73-9.
Murphy WG, Kelton JG. Methyldopa-induced autoantibodies against red blood cells. Blood Rev. 1988;2:36-42.
Johnson ST, Fueger JT, Gottschall JL. One center's experience: the serology and drugs associated with drug-induced immune hemolytic anemia--a new paradigm. Transfusion. 2007;47:697-702.
Blajchman MA, Lowry RC, Pettit JE, Stradling P. Rifampicin-induced immune thrombocytopenia. Br Med J. 1970;3:24-6.
Oostendorp M, Lammerts van Bueren JJ, Doshi P, Khan I, Ahmadi T, Parren PW, et al. When blood transfusion medicine becomes complicated due to interference by monoclonal antibody therapy. Transfusion. 2015;55(6 Pt 2):1555-62.
Hosokawa M, Kashiwagi H, Nakayama K, Sakuragi M, Nakao M, Morikawa T, et al. Distinct effects of daratumumab on indirect and direct antiglobulin tests: a new method employing 0.01 mol/L dithiothreitol for negating the daratumumab interference with preserving K antigenicity (Osaka method). Transfusion. 2018;58:3003-13.
Plesner T, Arkenau HT, Gimsing P, Krejcik J, Lemech C, Minnema MC, et al. Phase 1/2 study of daratumumab, lenalidomide, and dexamethasone for relapsed multiple myeloma. Blood. 2016;128:1821-8.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
